Operating Lease, Right-of-Use Asset of BIOMARIN PHARMACEUTICAL INC from 31 Mar 2019 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
BIOMARIN PHARMACEUTICAL INC quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 31 Dec 2024.
  • BIOMARIN PHARMACEUTICAL INC Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2024 was $28,680,000, a 33% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

BIOMARIN PHARMACEUTICAL INC Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $28,680,000 -$14,051,000 -33% 31 Dec 2024 10-K 24 Feb 2025 2024 FY
Q4 2023 $42,731,000 +$7,796,000 +22% 31 Dec 2023 10-K 24 Feb 2025 2024 FY
Q4 2022 $34,935,000 -$3,263,000 -8.5% 31 Dec 2022 10-K 26 Feb 2024 2023 FY
Q4 2021 $38,198,000 -$7,816,000 -17% 31 Dec 2021 10-K 27 Feb 2023 2022 FY
Q4 2020 $46,014,000 -$3,031,000 -6.2% 31 Dec 2020 10-K 25 Feb 2022 2021 FY
Q3 2020 $45,764,000 -$5,520,000 -11% 30 Sep 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 $47,246,000 -$3,950,000 -7.7% 30 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 $49,116,000 +$4,890,000 +11% 31 Mar 2020 10-Q 01 May 2020 2020 Q1
Q4 2019 $49,045,000 31 Dec 2019 10-K 26 Feb 2021 2020 FY
Q3 2019 $51,284,000 30 Sep 2019 10-Q/A 04 Nov 2019 2019 Q3
Q2 2019 $51,196,000 30 Jun 2019 10-Q 02 Aug 2019 2019 Q2
Q1 2019 $44,226,000 31 Mar 2019 10-Q 29 Apr 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.